Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

05/08/2021 08:30

Aug 5 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Sep 30, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             25.50               24.90            34.70    
                 (+2.4 pct)          (-8.9 pct)       (+2.7 pct)  
  Operating          3.60                2.22             2.86    
                 (+62.0 pct)         (-40.3 pct)      (-9.0 pct)  
  Recurring          3.60                2.15             2.81    
                 (+67.6 pct)         (-42.1 pct)      (-5.9 pct)  
  Net                2.64                1.57             2.10    
                 (+68.8 pct)         (-37.9 pct)      (+0.7 pct)  
  EPS             95.24 yen           50.24 yen        67.40 yen  
  Ann Div                             29.00 yen        29.00 yen  
  -Q2 div         14.00 yen           14.00 yen                   
  -Q4 div                             15.00 yen        15.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T